| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  HBR Innovation "If you take care of your employees, they will take care of your company" (R. Branson) Do you want to improve the working conditions of your employees? You have already identified, in your company, positions with physical constraints and where you encounter problems of musculoshered skeletal disorders (TMS). Wondering if exoskeletons are the solution for your business/establishment? Do not hesitate to contact us at: E-mail: contact@hbrinnovation.fr Tel: 05 56 14 30 56 We will analyze the workstations together in order to find the most relevant solution for your organization. What is an exoskeleton? This is a device that limits muscle … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 |
 | Syngulon Original genetic technologies using bacteriocins. Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a “Startup in the Labs”, meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 2 |
 |  VRG Therapeutics Regional leader in preclinical R&D with a world-class protein evolution tech platform for CGT applications Our mission is to cure diseases via targets and MoAs that cannot be reached with traditional approaches. Leveraging our unique platform, we optimize peptides/proteins of natural origin using directed evolution to create cutting-edge CGT products or peptide-based pharmaceuticals. VRGT’s management and staff members were selected based on their international research experience and outstanding pharma industry achievements. Our people have outstanding professional expertise in preclinical/clinical R&D and scientific project management, pharmacology, business development and medical marketing. For years, they have worked in the most prestigious academic … 158 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 27 |
 | Vivani Vivani Medical is a pre-clinical-stage developer of long-term pharmaceutical implants aimed at revolutionizing the treatment of patients with chronic diseases. Leveraging its proprietary NanoPortalTM platform, Vivani’s portfolio of tiny, sub-dermal drug implants address medication non-adherence by providing steady levels of medication over a target duration of six months or longer. Vivani is developing two miniature, long-term GLP-1 implants for the treatment of obesity and chronic weight management: NPM-115 (exenatide) and NPM-139 (semaglutide). In addition, the company is developing NPM-119, a lower dose exenatide implant for the treatment of type 2 diabetes. Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 28 |
 | Eurofins BioPharma Product Testing Italy Laboratory Testing Excellence Eurofins Biolab S.r.l. is a GMP & GLP Laboratory part of the BioPharma Product Testing Division of Eurofins Scientific. Pharmaceuticals, Medical Devices, Biocides and Cosmetics are our main areas of interest GMP, GLP, ISO 17025, ISO 9001, ISO 13485, ISO 22716, FDA INSPECTED, BioPharmaceutical Testing, Medical Device Testing, Biocide Testing, Cosmetic Testing, Professional Scientific Services, Regulatory and Consultancy, Microbiological and Chemical Testing, Training, and Laboratory Testing 63 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 460 |
 | Centennial Optical Limited Centennial Optical is an independent, Canadian-owned company since 1967. Keeping You in Sight Centennial Optical is an independent, Canadian-owned company distributing ophthalmic frames and lenses, sunglasses, lab supplies, cases and accessories, nationally and internationally. Founded in 1967, Centennial sells optical goods and services to Eye Care Professionals (Optometrists, Opticians and Ophthalmologists), optical laboratories and optical retailers. Centennial is fully licensed by Health Canada to sell Class I and Class II medical devices. With corporate headquarters and central distribution located in Toronto, Centennial also has local distribution centers and customer service in Montreal and Vancouver. Toujours en vue Optique Centennial est … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 91 |
 | Keeler Helping our customers bring an end to preventable vision loss across the globe. While you may already know Keeler for our trusted slit lamps or our cutting-edge binocular indirect technology, we offer much more than meets the eye! See us in a new light: https://www.keelerglobal.com/more-than-meets-the-eye With over 100 years of expertise, we are focused on supporting your in-practice and on-the-go needs. Designed in collaboration with clinicians, equipped with exceptional optics and featuring ergonomic shapes and controls, Keeler products are robust, intuitive and comfortable. Beyond being a manufacturer, we are your collaborator within the eyecare industry. We are committed to knowledge … 2 similar entities Type: SMB Activities: manufacturing healthtech Technologies: Synthetic Biology | 1 | 217 |
 | Karten Design We Create Extraordinary Experiences In Healthcare Karten Design is an award-winning product design and innovation consultancy passionate about creating extraordinary experiences between people and products. For 40 years, we have helped leading consumer product and medical device companies seize new opportunities, build their brands, and generate revenue by designing and developing beautiful, easy-to-use products that resonate with end users. EXPERTISE Medical Product Innovation Inspired by deep empathy for the needs of patients, caregivers, and clinical professionals, we create health solutions that people love, increasing adoption and adherence. Digital Health Product Innovation Leveraging our 30 years of experience translating people’s complex … 36 similar entities Type: SMB Activities: uxtech Technologies: Synthetic Biology | 0 | 11 |
 | Sahajanand Medical Technologies Pledge to save millions At SMT (Sahajanand Medical Technologies), we are revolutionizing healthcare through innovation and clinical excellence. As a multinational MedTech company with diversified manufacturing facilities and operations across multiple countries, SMT is at the forefront of high-end cardiovascular, endovascular, and structural heart devices. Guided by our mission, “Pledged to Save Millions,” we specialize in developing clinically proven solutions for coronary interventions, occluders for congenital defects, and structural heart therapies. Our products undergo rigorous clinical trials and are featured in world-class medical journals like The Lancet, New England Journal of Medicine, BMJ Open, and JACC, cementing our position as … 63 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology | 0 | 918 |
 | Elektronik Electronics - the platform for expert knowledge. News and specialist articles for engineers, technical developers and researchers. Print & amp; Digital - handpicked by our editorial team. The 'electronics' specialist medium informs about solutions and components of professional electronics. We map the "hot" topics along the value chain and offer a comprehensive overview of manufacturers and distributors. This makes our 'electronics' brand unique in B2B communication. From research to technology illustration and rounded through the relevant economic and trend topics, the 'Electronics' is the perfect source of information for electronics developers, technical purchasing/sales/business development and support engineers. We are media … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 16 | 59 |
 | Pietro Turilli Senior Vice President, External Affairs at the TB Alliance. Helping to build the political will and mobilize resources necessary to end TB. Views are my own. Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | N/A |
 | Blythedale Children's Hospital We are a specialty children's hospital dedicated to improving the health of all kids with complex medical conditions. Blythedale Children's Hospital in Westchester County, New York is dedicated exclusively to the diagnosis, care and treatment of children with complex medical and rehabilitative needs. Blythedale is a national leader in developing innovative, multi-disciplinary inpatient and ambulatory programs, as well as a community resource for children with a variety of medical concerns. Acquired Brain Injury, Assistive Technology, Cancer Rehabilitation, Cardiac Rehabilitation, Complex Chronic Conditions, Complex Post-Surgical Rehabilitation, Complex Wound and Burn Management, Neuromuscular Disorders, Post Acute Neonatal Care, Pre/Post Organ & Stem … Type: SMB Activities: healthtech kidtech Technologies: Synthetic Biology | 2 | 442 |
 | Hospital Universitario Nuestra Señora del Rosario Open hospital in which we combine humanization and technical, welcome and professionalism, demand and affection. Our Lady of the Rosary Hospital is a reference surgical medical center, managed by the Congregation of the Sisters of the Charity of Santa Ana, located in the center of Madrid. With a wide range of specialties and a neonatological and adult emergency department that works 24 hours a day, it stands out in the fields of neurosciences (neurology, neurosurgery, endovascular therapy and neurodiagnosis by image), cardiology, obstetrics and gynecology, orthopedic surgery and traumatology, plastic and repair and repair surgery Urology It has a state … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 384 |
 | Molecular Partners Pioneering DARPin Therapeutics for Patients Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA. DARPins, Oncology, Immuno-Oncology, Radiopharmaceuticals, … 82 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 176 |
 | PHSE Delivering life science 🚚✈️🚢🏥💊❤️ Founded in 1999, PHSE is today a market leader providing GDP compliant time-critical and temperature-sensitive transport solutions to the pharmaceutical, biotech and life sciences industry, serving the hospital, home care and clinical research channels. It ranks internationally among the few providers specialising exclusively in the healthcare segment and in the management of worldwide shipments by air, land and sea of pharmaceuticals, radiopharmaceuticals, biotech, clinical trials, biological samples and celle & gene therapies, at any required temperature conditions. The year 2020 marks an important step in the development of PHSE's international platform, which counts 5 acquisitions between … Type: SMB Activities: healthtech transporttech deeptech Technologies: Synthetic Biology | 0 | 204 |
 | Physiogenex Leading preclinical CRO specializing in metabolic disorders. Physiogenex is a leading preclinical research organization (CRO) specializing in metabolic disorders such as diabetes, insulin resistance, obesity, fatty liver (NASH / NAFLD), dyslipidemia, atherosclerosis and cardiovascular complications. We provide: - Classical and proprietary diet-induced in vivo models - Innovative in-house techniques (RCT) and gold standard methods (glucose clamps with radiolabelled tracers, ...) - In vivo preclinical imaging services Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions … 63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 24 |
 | Fresenius Kabi France FreSenius Kabi is a global health company specializing in drugs and vital medical devices in infusion, transfusion and clinical nutrition. Fresenius kabi's drugs, technologies and services are used to help treat patients in emergency situations or with chronic diseases. The FreSenius Kabi product portfolio includes a full range of generic drugs administered intravenously, infusion therapies, clinical nutrition products as well as the medical devices necessary for the administration of these products. In the field of biosimilars, we focus on autoimmune diseases and oncology. In 2019, the first biosimilar product of Fresenius Kabi was launched. In the field of transfusion medicine … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 15 | 471 |
 | Sonoscanner - Premium Ultrasound Scanners Premium ultrasound diagnosis ➡ Are you doctors or health practitioners? ➡ Do you practice ultrasound or want to integrate ultrasound into your daily practice? Take advantage of Sonoscanner ultrasounds, manufactured in France! At Sonoscanner, a French manufacturer of ultrasounds, we believe that each doctor deserves the best of innovation and support to establish precise diagnoses while taking pleasure in their practice. More than 4,400 doctors practice ultrasound daily thanks to Sonoscanner. Our range revolves around 3 models of ultrasounds, to adjust your need perfectly. ✅ Portable ✅ Ultra-portable ✅ Stationary Our ultrasounds are recognized for their exceptional quality in terms … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 5 | 36 |
 | Texcell Expert in viral safety since 1987. Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades. Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing. Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays What do we provide ? A specialized analytical lab for your preclinical and clinical studies, including: - Cell based … 11 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 107 |
 | Thuasne Thuasne® imagines, develops and manufactures medical devices allowing everyone to become actors in their own health. For 6 generations and with its 2,400 employees, the Group offers concrete, adapted and innovative health solutions in the fields of orthopedics, medical compression, and sport. www.thuasne.com Thuasne® imagine, développe et fabrique des dispositifs médicaux permettant à chacun de devenir acteur de sa propre santé. Depuis 6 générations et fort de ses 2 400 collaborateurs, le Groupe propose des solutions de santé concrètes, adaptées et innovantes dans les domaines de l’orthopédie, de la compression médicale et du sport. www.thuasne.fr Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 27 | 736 |
 |  Medincell Better Medicine For All Better Medicine for All MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. … 73 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 20 | 157 |
 | Innov'Pulse InnovPulse is a medical devices company based out of France. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 4 | 2 |
 | GOBIO - Europe Technologies Operator assistance solutions - Exoskeletons and Zero Gravity The Gobio team comes from the industrial world and meets the needs of customers based on the latest mechanical or cobotics technologies, which it adapts to their uses. The team thus develops a full range of operators assistance devices with: - Ergoskeletons and exoskeletons - Articulated zero -seated arms These solutions meet the different needs of companies in terms of industrial or logistical applications. Innovative team, Gobio provides an individualized response to professionals anxious to improve the working conditions of their employees. exoskeleton, ergoskeleton, zero gravity, MSD, arduousness, and assistance to the … Type: SMB Activities: industry 4.0 Technologies: Synthetic Biology | 17 | 5 |
 | Microsynbiotix, Ltd. A Sundew company We are creating a potentially revolutionary algal platform technology. Thanks to major advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. The cost of the synthetic biology tools has dropped. We are building our technology based on solid, peer-reviewed science[1][2][3][4]. By using microalgae as an oral delivery vehicle, we can substantially cut the labor and post-processing production costs, allowing us to produce effective vaccines that are much more affordable and user-friendly. Our technology can reduce or eliminate the use of antibiotics, reduce fish mortality rates … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 51 |
 | Mursla Bio Unlocking organ-specific intelligence in blood for cancer detection Mursla Bio is a pioneering biotech company on a mission to transform cancer care by pushing the boundaries of biopsy technology. Its breakthrough Dynamic Biopsy platform combines the data richness of tissue biopsy with the convenience of liquid biopsy. Dynamic Biopsy is made possible by coupling the latest of extracellular vesicle (EV) and extracellular omics science with Mursla Bio’s pioneering EV technologies. Mursla Bio’s initial focus is to transform the surveillance of liver cancer in high-risk populations - the fastest growing cause of cancer related deaths. Mursla Bio is currently conducting a … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 16 |
 | Inspire Medical Systems We are committed to elevating and redefining the standard of care for Obstructive Sleep Apnea. Inspire Medical Systems, Inc. has developed the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient’s unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition. Obstructive Sleep Apnea, ENT, sleep, patient engagement, digital health, medical device, medical devices, Sleep Apnea, Healthcare, … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 1,284 |
 | OrthoHeal Healing Comfortably ! OrthoHeal is the leading Medical Technology (Med-Tech) company that specializes in the orthopedic medical devices. We relentlessly strive to intensively research and innovate technologies by discovering newer horizons of potential solutions for improving patient-care and state-of-the-healthcare. We specifically emphasize on improving the experience for post-operative orthopedic recoveries while also discovering, inventing and enhancing the potentials for comfort and convenience in healthcare. Leveraging our knowledge and technology OrthoHeal has flourished as a company with several innovative products with disruptive technologies under the brand-name FlexiOH®. FlexiOH® is the next generation orthopedic immobilization technology invented, developed, patented and delivered world-wide … Type: Startup Activities: healthtech martech deeptech Technologies: New Materials Synthetic Biology | 1 | 73 |
 | CITO Medical New Product Development of Medical Devices & Biotech Instruments CITO Medical is an engineering firm specializing in new product development of medical devices, life science lab equipment, point of care diagnostic instruments and microfluidic cartridges. CITO partners with technology startups, Fortune 500 companies and academic institutions to bring product and research ideas to life through precision engineering, innovative hardware and solution-driven design and development. A unique blend of engineering principles and modern design techniques enable our engineers to turn your ideas into working products and solutions that transform everyday life around the world. Core capabilities include: Mechanical Engineering, Electrical Engineering, … 60 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology | 0 | 13 |
 |  AbiliLife Join us on our mission to reduce back injuries and create a safer workforce with the Calibrace+ back brace. AbiliLife is a leading medical technology company transforming how people manage their mobility and balance challenges. Our innovative products are designed to enhance the quality of life and empower individuals to live independently and pain-free. Our flagship product, the Calibrace+, is a unique back brace that provides targeted support to the trunk and helps improve posture and balance. The Calibrace+ is a game-changer for workforces. Back injuries and pain are common problems in many industries, reducing productivity, absenteeism, and healthcare costs. … Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology | 0 | 1 |
 | Cogentis Therapeutics, Inc. Developing first in class therapies for the treatment of dementia. Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying therapeutic for dementias such as frontotemporal dementia (FTD) and Alzheimer’s disease (AD) to improve patients’ quality of life and reduce the burden of disease on their families, providers, and the overall healthcare system. Our immediate goal is to develop a peptide-based compound, CT-526, for FTD. neurodegeneration, neuropeptide, frontotemporal dementia, Alzheimer's disease, and progressive supranuclear palsy 33 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 7 |
 | Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR TTM) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers. oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune 12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 251 |
 | SOMAVAC® Medical Solutions, Inc. Pioneering SOMAVAC® Deep Tissue Negative Pressure Therapy. SOMAVAC® Medical Solutions, Inc. is a MedTech company developing negative pressure therapy solutions for breast cancer recovery. Our platforms are led by our patented SOMAVAC® Deep Tissue Negative Pressure Therapy which is the first powered negative pressure therapy device cleared for seroma prophylaxis. For patients undergoing breast reconstruction and/or mastectomies, negative pressure delivered by SOMAVAC® removes fluid as it is produced, obliterates dead space, and holds tissues together which have been shown to prevent seromas. Seromas can lead to surgical complications like surgical site infections, wound dehiscence, etc. SOMAVAC® is FDA cleared for … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 10 |
 | IBT-Bioservices Accelerating research & development Integrated BioTherapeutics LLC (IBT Bioservices) is a contract research organization (CRO) offering in vitro and in vivo services as well as products to support your biomedical research and development needs. Whether you are a biotech startup or an established pharmaceutical company, IBT serves as your trusted partner, simplifying the development process and accelerating your journey toward bringing innovative biotherapeutics to patients in need. The team of highly skilled scientists, researchers, and industry experts at IBT work collaboratively to deliver exceptional results and accelerate the development process for its clients. By offering comprehensive services and concierge-level support … 2 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 11 |
 | Neopharm Boston CRO with extensive expertise in small molecule chromatography and purification We are Neopharm Boston Inc., formerly Averica Discovery Services, a Contract Research Organization (CRO) recognized by our proficiency in small molecule analysis and purification. Our enduring legacy of excellence positions us as a strategic partner within the pharmaceutical industry. Our recent expansion has equipped us to deliver a comprehensive, fully integrated array of services, facilitating a seamless journey from development and preclinical stage to commercial launch. At Neopharm Boston, our remarkable high throughput capabilities extend beyond advanced instrumentation to encompass a highly skilled and capable team. This synergy enables us … 62 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 160 |
 | OneSkin Science-based solutions designed to maximize your healthspan. OneSkin is a longevity company on a mission to transform the way we think about skin and aging. Founded by a team of four female PhDs, OneSkin’s products focus on skin longevity. OneSkin’s proprietary peptide, OS-01, is the first ingredient designed to reduce skin's biological age by improving skin barrier, supporting DNA damage repair, and preventing the accumulation of aged cells. Data-driven Science , Human 3D Skin Models, and Genomics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 50 |
 | Quevos Quevos are high protein, low carb chips made from egg whites. Finally a delicious snack you can feel great about eating! The original egg white chips! Quevos are high protein, low carb chips made from egg whites. Finally, a delicious snack you can feel great about eating! Type: Startup Activities: foodtech Technologies: Synthetic Biology | 3 | 3 |
 | Rebion Rebion provides a “Window to the Brain” to identify functional impairment of between the brain/eye pathway. Based on years of research and trials at major medical institutions, Rebion is commercializing the breakthrough Neural Performance Scanning (NPS) to identify and help manage life-altering diseases that manifest from functional impairments in the brain. NPS portable point-of-care devices provide previously unavailable information for fast and impactful triage, making early disease detection, intervention and customized treatment more accessible. Medical Devices, Optics, Vision Screening, Amblyopia, and Strabismus 10 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 14 |
 | Enable Injections, Inc. Enable's body-worn enFuse® drug delivery technology delivers large volumes (5 - 25mL) via subcutaneous administration. Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable's body-worn enFuse® delivers large-volume therapeutics via subcutaneous administration, with the aim of improving convenience, potentially supporting improved safety outcomes, and advancing healthcare system economics. For more information, please visit www.enableinjections.com. *Approved in the United States in combination with a specific drug, more information: https://enableinjections.com/our-products. combination product, patient-centric technology, subcutaneous drug delivery, high-viscosity, wearable drug delivery device, large volume drug delivery device, enFuse, on-body … Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology | 6 | 193 |
 | Mymee Mymee identifies unique dietary and environmental factors that can worsen autoimmune disease & COVID long haul symptoms. Mymee is the first personalized trial & care platform that helps patients gain control of unpredictable flares associated with autoimmune disease and long COVID. Autoimmune Disease, N of 1, Chronic Disease, Precision Medicine, Digital therapeutics, Population Health, Digital Care, Digital Health, Autoimmunity, Personalized Trials, Women's Health, and Long COVID Type: Startup Activities: healthtech Technologies: Synthetic Biology | 3 | 10 |
 | Likarda Improving the Efficacy of Cellular Therapies Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Our revolutionary method to coat cells with stealth hydrogels, called Core Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body. Unlike our competitors, Likarda has developed a library of over 50 different hydrogel formulations that work with Core Shell Spherification®, resulting in the ability to uniquely tailor the coating molecules to the specific requirements of the therapeutic cells themselves. From durable and long-term coatings to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 13 |
 | Epizyme On August 12, 2022, Epizyme was acquired by Ipsen, expanding Ipsen’s oncology portfolio. Epizyme now operates as an Ipsen company with a shared goal of delivering innovative treatment options to underserved patients. Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of … 10 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 99 |
 | Optinose As of May 21, 2025, Optinose was acquired by Paratek Pharmaceuticals. Please follow @Paratek for the latest updates and information about the acquisition. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 141 |
 | Venatorx Pharmaceuticals, Inc. Discovering & developing novel anti-infectives to treat multi-drug resistant bacterial & hard-to-treat viral infections. Venatorx Pharmaceuticals is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. antibiotics, antiinfectives, antivirals, drug development, drug discovery, pharmaceuticals, #battlesuperbugs, #WorkingToFightAMR, clinical, research, #squashsuperbugs, biotech, and antimicrobialresistance 81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 72 |
 | Quanterix Discovery Fueled by Ultra-Sensitivity Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research … 92 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 16 | 430 |
 | MEDGENOME Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is … 41 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 6 | 870 |
 | H3 Biomedicine Human. Health. Hope. H3 Biomedicine is a privately held biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet needs of genetically defined patient populations. H3 has leveraged its integrated expertise in genomics, tumor biology, bioinformatics and innovative synthetic organic chemistry to create an integrated drug development ecosystem to deliver patient-based, genomics-driven, small molecule drugs. In less than three years, H3 has developed four discovery platforms, which have produced two drug candidates for which the company expects to file investigational new drug (IND) applications in late 2015. Founded by a $200 million dollar … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 38 |
 | FULFIL FULFIL bars are packed with protein, have less than 3g of sugar, 9 vitamins and taste unreal! #LifesWonderfuel FULFIL bars are packed with protein, 9 vitamins, have less than 3g of sugar and taste amazing! Talk about feeding the dream #LifesWonderfuel Type: Startup Activities: foodtech Technologies: Synthetic Biology | 4 | 16 |
 | Medical Optometry America MOA helps preserve the beauty of sight by expanding access to high-quality medical eye care. Medical Optometry America (MOA) helps preserve the beauty of sight by expanding access to high-quality medical eye care. Our medical optometrists have received extensive additional training and are committed to excellence in visual and ocular health. Their experience, supported by the advanced technology available at the MOA Diagnostic and Therapeutic Center, enables them to provide exceptional patient outcomes. With Medical Optometry America, you get the best of today’s leading medical science with personalized care from our primary eye care doctors. Medical Optometry, Medical Eye Care, … 14 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 14 |
 | Sensing Future Technologies a greater step Welcome to Sensing Future Technologies! We are manufacturers of technological medical devices for the global market. We produce: - Force and pressure platforms for balance assessment and training; - Active and passive robotic systems; - We develop our own software. We raise the standards of physical and vestibular rehabilitation thinking about all those who suffer from balance disorders. We are certified by ISO 9001 and ISO 13485 standards for medical devices. Dispositivos Médicos, Telemedicina, Robótica, Robótica Médica, Inovação, Fisioterapia, Reabilitação, Hardware, Software, Medical Devices, Telemedicine, Robotics, Medical Robotics, Inovation, Physiotherapy, Rehabilitation, vestibular rehabilitation, and pressure sensors 69 similar entities Type: Startup Activities: healthtech deeptech Technologies: Robotics Synthetic Biology | 0 | 10 |
 | Ophthalmology Times As aging patients increase in number, ophthalmologists and optometrists face regulatory obstacles, reimbursement delays, and limited resources for technology. The tools and knowledge we provide to eyecare professionals help improve the delivery of progressive eye health from provider to patient. Ophthalmology, Eyecare, Glaucoma, Cataract, Refractive, and Retina 23 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 31 |
 | Numalogics Insight into the biomechanics of human-device interaction Numalogics virtual lab provides insight into the biomechanics of human-device interaction. Simulation, Biomechanics, sportsgear, and medical devices 77 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 13 |
 | Medicenna Therapeutics Corp. Evolutionary Cytokines | Revolutionary Medicines | TSX: MDNA | OTCQX: MDNAF Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines. Medicenna's long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior CD122 binding without CD25 affinity thereby preferentially stimulating cancer killing effector T cells and NK cells. Medicenna’s early-stage BiSKITsTM program, (Bifunctional SuperKine ImmunoTherapies) is designed to enhance the ability of Superkines to treat immunologically “cold” tumors. Medicenna's IL-4 Empowered Superkine, MDNA55, has been studied in 5 clinical trials including a … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 24 |
 | mimiX Biotherapeutics Next Generation Biofabrication - Sound Induced Morphogenesis //Acoustic biofabrication MimiX biotherapeutics introduces Sound Induced Morphogenesis. We extend the boundaries of biofabrication, making bioengineered, artificial human organs and tissues a future reality. Sound Induced Morphogenesis (SIM) is a revolutionary approach in biofabrication. It mirrors nature’s design, to aggregate and pattern biologicals by tuning sound profiles under contactless, fast and delicate culture conditions resulting in a morphologically induced tissue generation. We introduce cymatiX®, a unique acoustic biofabrication solution that makes the Sound Induced Morphogenesis technology easily accessible to the scientific and clinical community Visit www.mimixbio.com to learn more. mimiX biotherapeutics is a … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 8 |
 | Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … 11 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 |
 | SYNEIKA Treatment of chronic pathologies by non-invasive neurostimulation Manufacturer of neuronavigators for TMS, Syneika offers therapeutic solutions to alleviate chronic neurological and psychiatric diseases using a non-invasive neurostimulation technique: neuronavigated Transcranial Magnetic Stimulation (TMS). Syneika One, the neuronavigator designed by Syneika, was developed in collaboration with doctors and nurses. It is a fully integrated neuronavigator offering precision and ease of use in daily work. Syneika One neuronavigation for TMS aims to make repetitive Transcranial Magnetic Stimulation therapy accessible to any care team. It has been designed to fit the time constraints of an intensive therapeutic activity. To this end, powerful algorithms … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 4 | 6 |
 | POLYVALAN Proteins Structures Got Easier With Crystallophores Emerged from academic research, POLYVALAN (IBS & ENS Lyon Spin-off company) is a young innovative company founded in December 2016 dedicated to structural biology. POLYVALAN competitive edge is its unique chemical approach allowing significant gain of effectiveness, time and/or precision for protein structure determination that allows an optimal use of the existing large equipments. structural biology, protein crystallization, crystallization screening, nucleating agent, phasing agent, crystallophore, structure determination, X-ray crystallography, and drug design 59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 2 | 3 |
 | VITROPEP To make syringe injections disappear! Vitropep customizes soluble microneedles patches made of biomaterials for transdermal injection Type: Startup Activities: greentech Technologies: Synthetic Biology | 11 | 3 |
 | CTIBIOTECH Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come … 4 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 23 | 21 |
 | Orakl Oncology Biology x AI-powered drug development platform to transform precision oncology. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics Synthetic Biology | 2 | 20 |
 | En Carta Diagnostics Diagnostics for better care, everywhere. Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions. synthetic biology, cell-free, biotech, and molecular sensing 60 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 5 | 12 |
 | Healshape A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products 61 similar entities Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology | 23 | 23 |
 | Cutting Edge SAS Over 20 years of experience dedicated to intraocular lenses manufacturing To design, develop and distribute innovative solutions in eye surgery contributing to patient well-being. We have over 20 years of experience dedicated to IOL manufacturing. Opthalmology, Intraocular Lenses, Medical Devices, Surgical, Cataract, Vitreoretinal, and Cornea 41 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 46 |
 | Pasithea A New Approach to treat Sleep Apnea Pasithea: A New Approach to Sleep Apnea Pasithea introduces a novel and groundbreaking non-invasive adaptive neuromodulation approach to address respiratory disorders. The applied stimulation elicits a response from the autonomic nervous system in the early phases of apnea. Clinical studies have shown that Pasithea's therapy is safe and well-tolerated, and that it can significantly improve respiratory disorders. The therapy is also non-invasive, which means that it does not require surgery or hospitalization. Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 1 | 4 |
 | TheraPPI Bioscience Targeting protein interactions for health Founded in 2023, TheraPPI Bioscience is a biotechnology company whose science originates from the CRCL (Centre de Recherche de Cancérologie de Lyon, France). We modify protein interactions to offer treatments where current therapies fail. Our approach represents a paradigm shift in tackling cancer resistance and non-curable rare diseases protein-protein interaction, PPI, small molecule, therapeutics, oncology, and rare disease 80 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 6 |
 | Athana Relief of heat puffs by cryotherapy Athana is a french start-up specializing in the commercialization of innovative solutions for women's natural well-being, Particularly for those suffering from the effects of menopause. We focus on improving quality of life by offering natural and effective alternatives to hormonal treatments, which are often associated with health risks. Our mission is to alleviate hot flashes, the most debilitating symptom of menopause, Affting 900 million Women Worldwide. To add this need, we have developed Two Flagship Products: Hera, a Portable Device That Uses Cryotherapy to Provid Instant Relief from Hot Flashes, and Moona, A Connected … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 11 | 9 |
 | IMD-Pharma SAS Rebalancing the immune system, resolving inflammation. Drug candidates from our molecular platforms normalize the immune system by downregulating pro-inflammatory immune response and upregulating regulatory immune response. IMD-Pharma S.A.S is a french biotechnology company conducting research and development of innovative drug candidates for immune-related inflammatory diseases. Founded in 2016, IMD-Pharma is a company from the Laboratoire de Chimie de Coordination (CNRS) and the Centre de Physiopathologie de Toulouse Purpan (INSERM/CNRS/Université Toulouse III). immuno-modulation, anti-inflammatory drugs, chronic inflammatory diseases, Multiple Sclerosis, Rheumatoid Arthritis, dendrimers, monocyte rehabilitation, and psoriasis 49 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 7 |
 | CERTIS Therapeutics Disruptive solutions for image guided therapies Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care. medical device, oncology, cardiology, MRI guided, and Thermal ablation 40 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 3 | 13 |
 | Corlieve Therapeutics At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders. Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders. 60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 |
 | BIOTIS Bordeaux Laboratory for the Bioengineering of Tissues (Mixed Research Unit: Inserm and Bordeaux University) The BioTis laboratory (Laboratoire de Bioingénierie Tissulaire – Laboratory for the Bioengineering of Tissues) is a “Mixed Research Unit” (#1026) that is comprised of personnel from the INSERM, the French national institute of health and medical research), and from the University of Bordeaux. The Unit is located on the 5th floor of the new Bordeaux Biologie Santé (BBS) building at the University of Bordeaux medical campus. BioTis has around 65 members including full time researchers, junior and senior professors in medicine/medical sciences, technical and support staff, post-doc … 27 similar entities Type: Public Research & Education Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 18 |
 | Emopsy By mixing the scientist and the clinic, Emopsy offers new tools for assessing emotional skills for psychologists. Type: Startup Activities: deeptech Technologies: Synthetic Biology | 15 | 2 |
 | BoneTag Reinventing orthopedics BoneTag is a french start-up, based in Montpellier, which is focused on the development of innovative medical devices in orthopedics. BoneTag is developing two medical devices: • INCESSU: A solution making total knee arthroplasties (TKA) smart and connected. This medical device allows the communication between the implanted TKA and the surgeon. The communicated data are: identification information about the TKA, temperature in contact with the bone and motion between the TKA and the bones. • KNEEMATICS: A dynamic 3D representation of the kinematics of total knee arthoplasties. This device allows the visualization in real-time, and in 3D, of … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology IoT | 1 | 6 |
 | MAAsiRNA MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). A significant challenge in the field of nervous system pathologies lies in the absence of effective treatments. MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). After over a decade of intensive interdisciplinary research, we have successfully developed a siRNA-based treatment for Charcot-Marie-Tooth disease type 1A (CMT1A), the most prevalent form of hereditary peripheral neuropathy. CMT1A affects 1 in 5000 people, comprising a total of 1.5 million individuals worldwide. Our current objective is to advance towards a patient-ready therapy. Our innovative therapeutic approach has the potential to … Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 1 | 6 |
 | Blue Bees Therapeutics Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay. This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG). Immunothérapie, Immuno-oncologie, pharma, Biotech, Immunologie, Oncologie, Cancer, Médicament, and Drug 176 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 9 |
 | Deeptope Advanced Antibody Expertise Deeptope's expertise lies in antibody charaterisation (epitope/paratope mapping) and optimisation using high throughput methods. antibody, paratope mapping, epitope mapping, and antibody optimisation 77 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 7 |
 | Kimialys Innovative biosensing solutions for diagnostic and pharmaceutical companies, leveraging our K-One® surface chemistry. We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world. Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 16 | 20 |
 | Sirius NeoSight New view for cancer Therapeutic Sirius Neosight is an innovative technological breakdown company which aims to become a key player in the detection of subclashed neo-cancers, relapses and therapeutic monitoring of patients thus offering a new look to doctors on the therapeutic efficiency implemented. Sirius Neosight operates a patented from a patented rupture technology from a consortium of academic laboratory experts in the field. 59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 8 |
 | EYE TECH CARE Ultrasound Cyclo Plasty = Focused, Adaptable, Proven EYE TECH CARE, based in Lyon, was founded in 2008 by experts in the field of therapeutic ultrasound. The company develops and markets medical devices for the non invasive treatment of eye diseases. Glaucoma and ocular hypertension affect some 12O million people around the world, but are diagnosed in only about 30% of cases. It is the second cause of blindness, according to WHO (World Health Organization). With the support of renowned scientific and financial partners, EYE TECH CARE has developed the EyeOP1, an unique therapeutic device. Its teams have designed the only … 7 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 26 |
 | Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique (LBTI) Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents … 17 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 53 |
 | NERVOSAVE THERAPEUTICS Innovative therapies for peripheral nerve diseases Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome. 9 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 4 |
 | Stent Up Stent'Up vise à sécuriser le traitement préventif des anévrismes cérébraux par la création d'un implant révolutionnaire. Stent Up, designs, manufactures, and markets medical devices dedicated to the treatment of strokes. 48 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology | 9 | 3 |
 | Catsalyze We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze. Type: Startup Activities: deeptech greentech Technologies: Synthetic Biology | 33 | 3 |
 | Cell&Soft Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish 35 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 6 |
 | Smart Immune Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T … 57 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 26 | 32 |
 | EVerZom Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this … 2 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 18 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 45 | 55 |
 | Lightinderm Develops innovative technological systems for skin care intended for home use. Lightinderm is a French start-up hosted at Cochin Hospital in Paris, which develops innovative technological systems for skin care for home use. Inspired by dermatological treatments, its multi-brewed innovation associates photobiomodulation for the first time, photo-assets capsules and tissue massages. This unique association activates the natural regeneration of cells and visibly improves the quality of the skin. 9 years of research - 43 patents - 7 clinical studies Medical Device and Cosmetics 19 similar entities Type: Startup Activities: deeptech healthtech manufacturing cosmetics Technologies: Synthetic Biology | 2 | 16 |
 | Rondol Group We created Rondol Industrie in 2012 with the goal of adapting Hot Melt Extrusion (HME) technology to the micro scale and to pharma standards and contributing therefore to better and cheaper healthcare. We are now HQ'd in Nancy, France. Rondol is a privately owned Deeptech company which patented the All-in-One Vertical twin screw extruder, representing a significant innovation in pharmaceutical manufacturing due to its capacity to increase the efficiency of drug formulation and delivery, and allowing for more effective therapeutic solutions. What sets this technology apart is its ability to handle complex formulations, enhance drug solubility, and improve bioavailability. These … Type: Startup Activities: it services manufacturing Technologies: Synthetic Biology | 10 | 12 |
 | BrainPlotting Human PK data from preclinical stages BrainPlotting is a french contract research organization company which offers his knowledge to predict the entrance of drugs into the brain To that end BrainPlotting developped in vitro models based on fresh human tissus and cells. BrainPlotting is incubated at the Brain and Spine Institute (ICM), Paris, France Our core business is the study of pharmacokinetics (PK) in the human brain. The molecules that we study can have CNS targets as well as peripheral targets. To study the brain's PK, BrainPlotting uses the most accurate predictive models and the most recent methods and tools. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 1 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … 3 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 38 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … 83 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 18 | 132 |
 | OREGA Biotech Discovery of novel immune checkpoint inhibitors for cancer immunotherapy OREGA Biotech specializes in the discovery and the development of first-in-class monoclonal antibodies for cancer immunotherapy. The company was incepted in 2010 and is managed by Jeremy Bastid, CEO and Gilles Alberici, President. The science at OREGA Biotech is based on the research conducted by its academic cofounders Nathalie Bonnefoy, Armand Bensussan and Jean-François Eliaou. Our in vivo screening approach aims at discovering and validating novel immune checkpoint inhibitors and regulators of anti-PD1 response. Our lead asset, an anti-CD39 monoclonal antibody, has been out-licensed to Innate (2016) Pharma and then partnered … 69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 6 |
 | Kallistem Kallistem is a biotech company specialized in spermatogenesis. The company was founded in 2012 with the objective to anticipate and treat male infertility. It promotes a technology and expertise developed by Philippe Durand and Marie-Helene Perrard, two internationally renowned scientists in the field of the reproductive biology and more specially in in vitro spermatogenesis. Kallistem has developed, in collaboration with its partners, original and innovating technologies of germinal cell culture for male fertility preservation and the treatment of male infertility. male fertility, cellular therapy, biology of reproduction, and testicular toxicology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 3 |
 | SGH Medical Pharma Your pharmaceutical industry’s partner, from OEM subcontracting to the design & manufacture of injected medical devices. SGH Medical Pharma results from the alliance of 3 plastic processing companies with a solid reputation of 30 years of know-how (Rovipharm, Eskiss, Stiplastics). The different facilities are certified ISO 13485, including clean rooms The SGH Medical Pharma group designs and produces innovative solutions for : - Drug and supplement administration for solid and liquid medicines : dosing syringes, measuring cups and spoons, single doses, pipettes for droppers and pill dispensers... - Pharmaceutical use : plunger for pre-filled syringes, pre-filled syringes... - IV diagnostics … Type: SMB Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 7 | 120 |
 | UseConcept Take care of the ergonomics of health products! Specialists in the ability to use medical devices. We help you design a relevant, intuitive, safe and pleasant to use product USeconcept supports you in the management of ergonomics in the design and improvement phases of your products and services. Specializing in usage innovations, we have special expertise in medical IT, medical devices as well as new technologies related to trade. We help you better understand the needs of your users and design a complete, intuitive, safe and pleasant product. These characteristics are now increasingly required by regulations and constitute an essential … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 4 | 11 |
 | HEALTIS "Where MRI meets Safety" HEALTIS is an experienced MRI safety and compatibility company located in Nancy, France. We are ISO/IEC 17025 accredited* and provide expert services in the following fields: • MRI Safety and Compatibility Assessment of Medical Devices (MRI safety testing laboratory) • Numerical Modeling • MRI Safety and Compatibility Training • Technical and Regulatory Support related to MRI Safety and Compatibility We perform tests in compliance with the following international standards: ASTM F2052 · ASTM F2213 · ASTM F2182 · ASTM F2119 · ASTM F2503 · ISO/TS 10974; and are an active participant in international normative groups. Additionally, … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 3 | 18 |
 | X'PROCHEM We produce customised chemical proteins to help our bio-pharms partners to accelerate their projects. 🧪 X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances. protein, purification, synthesis, protein production, peptide synthesis, and life sciences 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 14 |
 | NEURO-SYS CNS/PNS - In vitro - In vivo - Drug Development Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s … 33 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 41 |
 | PhinC Development 15 years of Quantitative Pharmacology Solutions applied to the development of drug candidates. PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 17 |
 | IDMED Innovative technology, safer outcomes. IDMED, a French company based in Marseille, develops and markets innovative medical devices in the fields of anesthesia and intensive care. Our products are used worldwide in operating theaters, intensive care units, neuro-ophthalmological consultations and research laboratories. Follow us on Facebook as well https://www.facebook.com/profile.php?id=100087269760737 Our products are commonly used in the areas of pupillometry, neuromuscular blockade monitoring and analgesia monitoring. IDMED develops products in collaboration with healthcare professionals. Innovation, reliability and relevance are the core qualities of our devices. We put our technical knowledge to the service of an improved everyday clinical practice. Healthcare, Medical device, … 96 similar entities Type: Startup Activities: deeptech manufacturing healthtech Technologies: Synthetic Biology | 5 | 36 |
 | PhysioAssist Physioassist Develops and Markets Simeox, an innovative airway clearance Device for patients with cf, copd, be Physioassist is a medical equipment company that has developed expertise in rheology, study of bronchial mucus physics. After several years of research, an effective pneumatic vibration signal was characterized to act on intra pulmonary mucus, liquefy and drain it. This signal is issued by the Simeox medical device, which stimulates bronchial mucus by successive depressions, while ensuring passive expiration. Simeox is intended for patients with chronic respiratory pathologies. COPD, Airway Clerance, Respiratory Device, and CYSTIC FIBROSIS Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology | 6 | 16 |